Gender
Male (n=61)
Female (n=34)
|
6 (66.7%)
3 (33.3%)
|
55# (60.4%)
31# (34.1%)
|
0.872
(Pierson’s Chi2 test)
|
Indication
Atrial fibrillation
Venous thromboembolism
Other
|
9 (100%)
0 (0%)
0 (0%)
|
72 (79.1%)
11 (12.1%)
8 (8.8%)
|
0.244
(Pierson’s Chi2 test)
|
DOAC
Apixaban
Dabigatran
Edoxaban
Rivaroxaban
|
2 (22.2%)
2 (22.2%)
2 (22.2%)
3 (33.3%)
|
17(18.7%)
12 (13.2%)
34 (37.4%)
28 (30.1%)
|
0.784
(Pierson’s Chi2 test)
|
Dosage
Once a day
Twice a day
|
5 (55.6%)
4 (44.4%)
|
62 (68.1%)
29 (31.9%)
|
0.444
(Pierson’s Chi2 test)
|